Large 5 country cohort study - No increased risk of hematologic malignancies (lymphoid or myeloid) in PsA pts treated with TNFi. In PsA overall compared to general population - moderately increased underlying risk of hematologic malignancies. @RheumNow #EULAR2022 ABST#OP0257 https://t.co/P846RupitR